Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W F Goins

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Gene Therapy|April 4, 2017
MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in ratsT Iida, H Yi, S Liu, et al.
Experimental Neurology|September 16, 1999
Engineering herpes simplex virus vectors for CNS applicationsD Wolfe, W F Goins, M Yamada, et al.
Gene Therapy|February 19, 1999
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neuronsD M Krisky, D Wolfe, W F Goins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2001
Herpesvirus-mediated systemic delivery of nerve growth factorD Wolfe, W F Goins, T J Kaplan, et al.
Journal of Virology|April 1, 1994
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeatsW F Goins, L R Sternberg, K D Croen, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Engineering herpes simplex virus vectors for human gene therapyJ C Glorioso, W F Goins, M C Schmidt, et al.
The Journal of Urology|May 9, 2001
Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunctionW F Goins, N Yoshimura, M W Phelan, et al.
Urology|May 30, 2001
Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE)N Yoshimura, M E Franks, K Sasaki, et al.
Gene Therapy|July 6, 2007
Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injuryR Kato, D Wolfe, C H Coyle, et al.
Gene Therapy|December 21, 2012
Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSVP-Y Wang, M A Currier, L Hansford, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Gene Therapy|April 4, 2017
MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in ratsT Iida, H Yi, S Liu, et al.
Experimental Neurology|September 16, 1999
Engineering herpes simplex virus vectors for CNS applicationsD Wolfe, W F Goins, M Yamada, et al.
Gene Therapy|February 19, 1999
Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neuronsD M Krisky, D Wolfe, W F Goins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 13, 2001
Herpesvirus-mediated systemic delivery of nerve growth factorD Wolfe, W F Goins, T J Kaplan, et al.
Journal of Virology|April 1, 1994
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeatsW F Goins, L R Sternberg, K D Croen, et al.
Advances in Pharmacology (San Diego, Calif.)|January 1, 1997
Engineering herpes simplex virus vectors for human gene therapyJ C Glorioso, W F Goins, M C Schmidt, et al.
The Journal of Urology|May 9, 2001
Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunctionW F Goins, N Yoshimura, M W Phelan, et al.
Urology|May 30, 2001
Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE)N Yoshimura, M E Franks, K Sasaki, et al.
Gene Therapy|July 6, 2007
Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injuryR Kato, D Wolfe, C H Coyle, et al.
Gene Therapy|December 21, 2012
Expression of HSV-1 receptors in EBV-associated lymphoproliferative disease determines susceptibility to oncolytic HSVP-Y Wang, M A Currier, L Hansford, et al.
Pageof 5